Frazier Life Sciences raises $1.3bn for biggest fund yet, 30% above last flagship fund total

Healthcare investor Frazier Life Sciences has sealed a $1.3bn final close for its latest flagship fund, which will target company creation and early-stage private biopharmaceutical business.